March 3, 2026

6 Critical Vulnerabilities in Connected Medical Devices and How to Patch Them

Spread the love

Interconnected medical devices store more than just information about patients; they store the health outcomes of those patients. If an infusion pump or ventilator is hacked, it’s not a data privacy issue that occurs but a dangerous event affecting vulnerable patients. This difference is crucial. And it explains why security methods that may work in traditional IT situations don’t sufficiently protect clinical systems.

Hard-Coded Credentials And Default Access

The most targeted entryway for IoMT devices is a vulnerability that manufacturers are aware of which involves hard-coded administrative credentials implanted within the firmware. These passwords have been made public on numerous forums, shared in analyst reports, and eventually are used by attackers. When someone obtains root control to a life-saving device, it is easy for them to move laterally throughout the hospital network.

The solution is simple in theory – have unique, rotatable credentials that are consolidated at the device level. However, manufacturers must reconstruct authentication streams which were originally integrated without the thought of being within a perilous network.

The Legacy Device Problem Won’t Patch Itself

A significant portion of deployed medical hardware runs on operating systems that no longer receive security updates. Windows XP-era devices are still active in clinical environments, often because replacement cycles take years and device recertification is expensive. These devices can’t run modern encryption. They don’t have the processing headroom for endpoint detection agents.

The practical answer here is network segmentation. Isolate these assets from the main hospital grid so that a compromise doesn’t become a hospital-wide incident. It’s not a permanent fix, but it’s a necessary control while the longer procurement cycle plays out.

What Patch Management Actually Looks Like In AHospital

Updating software on a hospital device differs vastly from updating a laptop. Each update must pass through a validation step – conducted in a sandboxed environment that replicates the clinical setting – before crossing over to the live device. This is done to ensure that the update doesn’t impair the device’s performance in any way, for instance, by causing timing conflicts or disturbing communication between the device and monitoring tools.

More ransomware attacks were reported on healthcare and public health systems than on any other critical sector, with unpatched medical devices being one of the primary access points cited by the FBI Internet Crime Complaint Center. The pressure to patch faster is great, as is the pressure to patch more safely, but speed and safety are at odds with each other and the answer is process, not velocity.

A Software Bill of Materials (SBOM) forms the basis of that process. Patching is a less stressful and more secure process when manufacturers have an updated list of all components. They can then determine which of the known vulnerabilities apply to specific versions in their library, categorize them based on how serious the issues they raise are, and decide which ones need to be addressed most urgently. If you do not have an SBOM, the process of patch management is largely reactive and most likely far from perfect.

Catching Vulnerabilities Before The Device Ships

The best time to detect a buffer overflow vulnerability is in the lab, not the wild. Binary analysis and fuzz testing during development – deliberately throwing malformed inputs at device software to find how it breaks – catches the kinds of memory corruption issues that attackers exploit through remote monitoring interfaces and clinical data endpoints.

This is where medtech cybersecurity functions as a distinct discipline rather than a subset of general IT security. The threat models are different. The regulatory requirements under frameworks like IMDRF guidance add compliance layers that don’t exist in commercial software development. And the consequences of a missed vulnerability aren’t measured in data exposure alone – they’re measured in device availability and patient risk.

Penetration testing, specifically against device firmware and the communication protocols connecting devices to clinical systems, should be a standard pre-market step. Using the MITRE ATT&CK for Healthcare framework to structure those tests gives manufacturers a realistic picture of actual threat actor behavior rather than generic attack scenarios.

Detection When Prevention Isn’t Enough

Even the most up-to-date devices can get compromised. For instance, real-time anomaly detection – looking for sudden spikes in data transmission, unexpected protocol requests, or communicating with external addresses – typically indicates to IT that a device has been breached. Furthermore, a device that transmits only small telemetry packets should not be suddenly generating high-volume outbound traffic.

This kind of behavioral monitoring of devices requires the implementation of detection systems early enough to learn what “normal” looks like. It also requires IT and clinical teams to communicate about what anomalies are operational issues and what anomalies should trigger a deeper security response.

Finally, encryption at rest and in transit closes another threat vector. Patient data in motion across a clinical network without proper encryption represents a risk of HIPAA non-compliance as well as an obvious attack vector. Devices that can’t support modern encryption standards simply fall out of the conversation above and need to be segmented on isolated networks or removed from the environment.

Security And Availability Aren’t Opposing Goals

The tension between adequate patching and continuously available devices is real. The good news is it’s manageable when controls like SBOM tracking, segmentation for legacy assets, validated patch workflows, pre-market testing, and behavioral monitoring complement each other.

Manufacturers and hospital security teams that view these as dual objectives, rather than competing priorities, often develop devices that are both safe to use and more difficult to compromise.